Obesity News

Aerobic exercise has been linked to reductions in several measures of body fat, including body weight and waist circumference, a systematic review and meta-analysis in JAMA Network Open found.

Men were less likely than women to have weight-loss surgery, and that gap has widened over time, while Black patients were less likely than those of other races to have a procedure, and that gap has narrowed slightly, new data show.

Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according to a presentation at World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.

A new international commission report has proposed new criteria for diagnosing obesity that could dramatically change the way it is categorized and managed in the future.

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without diabetes, a systematic review published in Annals of Internal Medicine showed.

Obesity at cancer diagnosis appeared linked to significantly poorer survival among children and adolescents, according to results of a retrospective study.

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering glucose levels and body weight.

Weight gain after a breast cancer diagnosis elevated a person’s risk for heart failure, according to results of an observational study in the Republic of Korea.

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to approximately 20% at 1 year in patients with overweight or obesity without a weight loss plateau, according to a presentation.